Targeting a blood stem cell subset shows lasting, therapeutically relevant gene editing – Science Daily
Targeting a blood stem cell subset shows lasting, therapeutically relevant gene editing Science Daily
Researchers have used CRISPR-Cas9 to edit long-lived blood stem cells to reverse the clinical symptoms observed with several blood disorders, including …
View full coverage on Google News
Source: Business News Feed